Dr. Timothy Low is a distinguished healthcare leader, physician, strategic investor, and digital brand builder with more than 30 years of experience spanning biopharma, medtech, hospital management, and wellness innovation across Asia-Pacific. Trained as a medical doctor, he brings clinical insight to leadership, enabling him to bridge science, business, and patient-centered care. As CEO of Gleneagles Hospital and Farrer Park Hospital, he pioneered technology-driven healthcare ecosystems, delivering multi-million-dollar growth and innovation. At Pavilion Capital (Temasek Holdings), he spearheaded investments in digital health and AI startups, achieving returns of over 3x MOIC. Today, as Executive Vice President at QuikBot Technologies, he advances precision in last-mile healthcare logistics. Beyond the boardroom, Dr. Low has built a strong personal brand on social media, where he shares thought leadership on digital health, regenerative medicine, and longevity science—engaging global audiences as a mentor, speaker, and advocate for transformative healthcare.
Prior to Skye, Ross was primarily in private equity, investing behind high quality companies in Europe and emerging markets. This included CDC Group, the UK’s Development Finance Institution, where I learned about ESG, sustainability and impact-focused investments. Ross built a company that could make a meaningful impact. Founded in 2021, the company aims to be part of the global energy transition, as companies seek to end their dependency on fossil fuels and move to renewable energy sources. Ross strongly believes that the move to renewable energy is no longer a nice-to-have, but an urgent and essential part of our shift to a more sustainable economy.
The expert resides in Singapore.
Dr Andreas Schmidt is a serial entrepreneur and successful biotech CEO. Following the recent acquisition of his startup Proteona by Singleron Biotechnologies he is currently heading the global business development with an emphasis on clinical and pharma collaborations enabling single cell and multi-omic precision medicine. Previously he has co-founded the venture capital backed proteomics company AYOXXA Biosystems. Dr Schmidt serves as board member, advisor and share holder of several biotech companies and investment funds centered in Asia, Europe and North America. His engagements are focussed on new approaches to precision medicine, multi-omics platforms, cell therapy and artificial intelligence enabled clinical research.
Anju Patwardhan is a distinguished figure in global finance, renowned as a Fintech Venture Capital (VC) investor, board director, and former banking executive. Over two decades, she held pivotal roles at Citibank and Standard Chartered Bank, shaping the financial landscape from Singapore to Silicon Valley. Serving as an Independent Non-Executive Director (INED) on boards in the US, the UK, Europe, Singapore, Saudi Arabia, and Thailand since 2011, Anju's impact spans continents. A Stanford alumna with a Fulbright Fellowship, she brings a rich tapestry of experience. Anju is a sought-after speaker on Fintech, Venture Capital, and topics like Longevity and Financial Well-being. Leveraging her background managing a $1 billion Fintech VC Fund, Anju provides strategic advisory services, offering unique insights into digital strategy, transformation, and BigTech considerations. With expertise in digital banking, risk management, and operations, Anju Patwardhan is a pioneering force shaping the future of finance globally.
KV Rao is a highly respected senior business leader with over 43 years of experience across global markets and industries. Currently the Resident Director – ASEAN at Tata Sons, he provides strategic leadership to Tata Group’s presence in Southeast Asia. A distinguished alumnus of the Indian Institute of Foreign Trade, KV specializes in international business and has operated in over 45 countries, excelling in cross-cultural leadership and global strategy. His career includes a significant tenure with the Singapore Civil Service and leadership roles across Tata Group entities, including as Chairman of Trust Energy Resources, Tata Power International, and Tata Capital’s Singapore-based ventures. Beyond the corporate realm, he actively contributes to public service and cultural development, serving on boards such as SIIA, SINDA, SBF, and SIFAS. As a keynote speaker, trainer, and columnist, KV Rao continues to shape regional business dialogues and foster India–ASEAN collaboration at both economic and societal levels.
Rina is a seasoned serial entrepreneur, impact investor, and venture capitalist with over 25 years of leadership experience across the Asia Pacific region. She is globally recognized for her efforts in promoting women's empowerment, driving innovation in education, and advancing sustainability for social enterprises. With a commitment to entrepreneurial excellence, governance best practices, and ESG principles, Rina has received numerous accolades, including the Top 10 Most Inspiring Businesswomen in Singapore (2014), Top 10 Women Venture Capitalists in Singapore (2016), Top 8 Trailblazers Under 40s (2017), the Asia Pacific Entrepreneurial Award (2018), the Most Admired Leaders Award (2019), and the Tan Sri Dato Napsiah Omar Women Leadership Award (2022). Through her impactful work, Rina continues to inspire and create transformative change across industries.
There are so many enticing Investment speakers just waiting to speak at your next event. Bringing a top speaker or expert to your event can be a game changer. Whether it is inspiring, engaging life stories or driving change within your organisation or institution. Connect with Best Investment speakers & leaders through Singapore Speaker Bureau; a platform where leading organisations partner for their business conferences and events – via keynote presentations, cross-industry interactions, inspirational and leadership sessions.
